Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-08-07
2007-08-07
McKenzie, Thomas (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S300000, C544S391000, C546S335000, C546S234000, C546S226000, C546S236000, C546S294000, C560S034000
Reexamination Certificate
active
10466665
ABSTRACT:
Novel antagonists of ∝4β1 integrin and/or ∝4β7 integrin of the general Formula I: wherein R1, R2, R5, L1, L2, Rb, W and Z are as defined in any one of claims1to13,A represents —CH— or a nitrogen atom, and p is from 0 to 4.
REFERENCES:
patent: 4705864 (1987-11-01), Cesa et al.
patent: 4740611 (1988-04-01), Cesa et al.
patent: 6353099 (2002-03-01), DeLaszlo et al.
patent: 199 09 979 (2000-09-01), None
patent: WO-92/08464 (1992-05-01), None
patent: WO 97/40031 (1997-10-01), None
patent: WO 98/04247 (1998-02-01), None
patent: WO 98/07718 (1998-02-01), None
patent: WO 98/53818 (1998-12-01), None
patent: WO 98/58902 (1998-12-01), None
patent: WO 99/11606 (1999-03-01), None
patent: WO 99/20617 (1999-04-01), None
patent: WO 99/24035 (1999-05-01), None
patent: WO 99/26921 (1999-06-01), None
patent: WO-99/31099 (1999-06-01), None
patent: WO 99/37604 (1999-07-01), None
patent: WO 00/35864 (2000-06-01), None
patent: WO 00/43415 (2000-07-01), None
patent: WO 00/51974 (2000-09-01), None
patent: WO 00/67746 (2000-11-01), None
patent: WO 00/71572 (2000-11-01), None
patent: WO 00/73260 (2000-12-01), None
patent: WO 01/14328 (2001-03-01), None
Hcaplus 108:131821.
Armstrong et al. (1995). “Highly enantioselective capillary electrophorectic separations with dilute solutions of the macrocyclic antibiotic ristocetin A,”J. Chromatography A689: 285-304.
Casini et al. (2000). “Carbonic Anhydrase Inhibitors: Water-Soluble 4-Sulfamoylphenylthioureas as Topical Intraocular Pressure-Lowering Agents with Long-Lasting Effects,”J. Med. Chem.43:4884-4892.
Bach Tana Jordi
Jimenez Mayorga Juan Miguel
Navarro Romero Eloisa
Ontoria Ontoria Jesus Maria
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Laboratorios Almirall S.A.
McKenzie Thomas
Robinson Binta
LandOfFree
Urea derivatives as integrin α4 antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Urea derivatives as integrin α4 antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urea derivatives as integrin α4 antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3897013